Fourth-Generation Chimeric Antigen Receptor T-Cell Therapy is Tolerable and Efficacious in Treatment-Resistant Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is an autoimmune inflammatory disease characterized by symmetric synovitis, leading to progressive functional disability in patients. Although monoclonal antibody therapies targeting cytokines (e.g., tumor necrosis factor-α, TNFα) and B cells (e.g., CD20-targeted antibody rituximab) have significantly improved RA treatment...

Therapeutic Potential of 2-Bromo-1,4-Naphthoquinone in Multiple Sclerosis

2-Bromo-1,4-naphthoquinone Promotes CD8+ T Cell Expansion and Limits Th1/Th17 Cell Development to Alleviate Experimental Autoimmune Encephalomyelitis Introduction Multiple Sclerosis (MS) is a chronic autoimmune disease that primarily affects the Central Nervous System (CNS), impacting approximately 3 million people worldwide. The onset of MS is ass...